CATX · Company research
Perspective Therapeutics, Inc. (CATX): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
19records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Perspective Therapeutics (CATX) Receives a Buy from Wedbush - The Globe and Mail | Perspective Therapeutics (CATX) Receives a Buy from Wedbush The Globe and Mail | View source ↗ | The Globe and Mail | Oct 14, 2026 | neutral | 0 | 0.6 |
| $CATX stock is down 9% today. Here's what we see in our data. - Quiver Quantitative | $CATX stock is down 9% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Oct 13, 2026 | neutral | 0 | 0.6 |
| Strength Seen in Profound Medical (PROF): Can Its 21.7% Jump Turn into More Strength? | Profound Medical (PROF) surged 21.7% following strong preliminary Q3 2026 revenue guidance of $9.8-10 million, representing 85-89% year-over-year growth and 45-47% above analyst consensus. The company expects gross margins exceeding 70%, signaling improved commercial momentum. However, with unchanged earnings estimate revisions over the past 30 days, analysts caution that the stock's momentum may not sustain without further positive estimate revisions. | View source ↗ | Zacks Investment Research | Oct 9, 2026 | bullish | 0.5 | 1 |
| With treatment options limited, a tumor therapy gets FDA Fast Track at Perspective Therapeutics (CATX). - Stock Titan | With treatment options limited, a tumor therapy gets FDA Fast Track at Perspective Therapeutics (CATX). Stock Titan | View source ↗ | Stock Titan | Oct 8, 2026 | neutral | 0 | 0.6 |
| Perspective Therapeutics, Inc. (CATX) Stock Price, News, Quote & History - Yahoo! Finance Canada | Perspective Therapeutics, Inc. (CATX) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 8, 2026 | neutral | 0 | 0.6 |
| Cancer-treatment data will get an oral presentation at a November medical symposium. - Stock Titan | Cancer-treatment data will get an oral presentation at a November medical symposium. Stock Titan | View source ↗ | Stock Titan | Oct 7, 2026 | neutral | 0 | 0.6 |
| $CATX stock is down 8% today. Here's what we see in our data. - Quiver Quantitative | $CATX stock is down 8% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Oct 5, 2026 | neutral | 0 | 0.6 |
| A study of a targeted melanoma treatment will be presented at a cancer meeting in November. - Stock Titan | A study of a targeted melanoma treatment will be presented at a cancer meeting in November. Stock Titan | View source ↗ | Stock Titan | Oct 2, 2026 | neutral | 0 | 0.6 |
| Catalyst One Exploration Corp. (CATX.V) Stock Forum & Discussion - Yahoo! Finance Canada | Catalyst One Exploration Corp. (CATX.V) Stock Forum & Discussion Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 1, 2026 | neutral | 0 | 0.6 |
| After selling nearly 1.4 million shares in one day, a Perspective Therapeutics (CATX) holder still has a stake. - Stock Titan | After selling nearly 1.4 million shares in one day, a Perspective Therapeutics (CATX) holder still has a stake. Stock Titan | View source ↗ | Stock Titan | Sep 23, 2026 | neutral | 0 | 0.6 |
| Merck provides Keytruda at no cost for a cancer trial - Stock Titan | Merck provides Keytruda at no cost for a cancer trial Stock Titan | View source ↗ | Stock Titan | Sep 14, 2026 | neutral | 0 | 0.6 |
| Are Medical Stocks Lagging Perspective Therapeutics, Inc. (CATX) This Year? - Yahoo Finance | Are Medical Stocks Lagging Perspective Therapeutics, Inc. (CATX) This Year? Yahoo Finance | View source ↗ | Yahoo Finance | Aug 4, 2026 | neutral | 0 | 0.6 |
| Perspective Therapeutics (CATX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now - Yahoo Finance Singapore | Perspective Therapeutics (CATX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now Yahoo Finance Singapore | View source ↗ | Yahoo Finance Singapore | Jul 29, 2026 | neutral | 0 | 0.6 |
| Is Perspective Therapeutics, Inc. (CATX) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance | Is Perspective Therapeutics, Inc. (CATX) Stock Outpacing Its Medical Peers This Year? Yahoo Finance | View source ↗ | Yahoo Finance | Jul 16, 2026 | neutral | 0 | 0.6 |
| Perspective Therapeutics taps Merck KGaA oncology chief in planned science shift - Stock Titan | Perspective Therapeutics taps Merck KGaA oncology chief in planned science shift Stock Titan | View source ↗ | Stock Titan | Jul 8, 2026 | neutral | 0 | 0.6 |
| Perspective Therapeutics, Inc. Actuals & Estimates (AMEX:CATX) - TradingView | Perspective Therapeutics, Inc. Actuals & Estimates (AMEX:CATX) TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| CATX Forecast — Price Target — Prediction for 2027 - TradingView | CATX Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| $CATX ($CATX) Releases Q1 2026 Earnings, Stock Rises | CATX Stock News - Quiver Quantitative | $CATX ($CATX) Releases Q1 2026 Earnings, Stock Rises | CATX Stock News Quiver Quantitative | View source ↗ | Quiver Quantitative | May 11, 2026 | neutral | 0 | 0.6 |
| Perspective Therapeutics, Inc. (CATX) Stock Price: Oct 5 Close $2.57 - Gotrade | Perspective Therapeutics, Inc. (CATX) Stock Price: Oct 5 Close $2.57 Gotrade | View source ↗ | Gotrade | Feb 2, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.